Mississauga, Canada

Novadaq Technologies, Inc.


USPTO Granted Patents = 30

% Expired Patents = 26.7



Trademarks = 7

Forward Citations = 1,085

Loading Chart...
Loading Chart...

36 inventors (with patents filed for the assignee):

goldMedal John Fengler (6 out of 11 patents)

silverMedal John J P Fengler (6 out of 13 patents)

bronzeMedal Paul Roald Westwick (5 out of 22 patents)

4.  Joachim W Boehm (4 out of 6 patents)

5.  John C Tesar (4 out of 40 patents)

6.  Frederick Allen Moore (3 out of 19 patents)

7.  T Bruce Ferguson, Jr (3 out of 13 patents)

8.  Cheng Chen (3 out of 20 patents)

9.  David Mark Henri Goyette (3 out of 7 patents)

10.  Peter Dvorsky (3 out of 7 patents)

11.  Paul Cottle (3 out of 4 patents)

12.  Lukasz Brzozowski (3 out of 10 patents)

13.  Gurpreet Mangat (3 out of 7 patents)

14.  Richard W Cline (3 out of 9 patents)

15.  Richard L Croft (3 out of 4 patents)


Core Competencies:
Multi-Channel Imaging
Near Infrared Imaging
Fluorescence Endoscopy
Optical Systems
LED Illuminators
Surgical Marking
Myocardial Tissue
Vasculature Visualization
Choroid Imaging
Retinal Imaging
Photocoagulation Therapy
Optical Coherent Imaging

30 patents:

Novadaq Technologies, Inc. is a prominent medical technology company based in Mississauga, Canada, specializing in advanced imaging solutions for surgical applications. The organization focuses on developing innovative fluorescence imaging systems that enhance visualization during surgical procedures, particularly in the fields of oncology and reconstructive surgery. By integrating real-time imaging capabilities, Novadaq aims to improve surgical outcomes and patient safety, positioning itself as a leader in the medical device sector.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Novadaq Technologies, Inc.
30 Patents

#31 in Mississauga

#463 in Canada

#21,853 in the World

Mississauga, CA
Mississauga, Canada
Forward Citations = 1,085

36 inventors:

Please report any incorrect information to [email protected]
Loading…